Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Gasherbrum Bio, Inc · Phase 3 · Recruiting · Enrollment 1100

NCT07654374

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
aleniglipron Arm 1n/rn/rn/rn/r
aleniglipron Arm 2n/rn/rn/rn/r
aleniglipron Arm 3n/rn/rn/rn/r
Placebo Arm 4n/rn/rn/rn/r

Not shown

  • aleniglipron Arm 1: endpoint not reported
  • aleniglipron Arm 2: endpoint not reported
  • aleniglipron Arm 3: endpoint not reported
  • Placebo Arm 4: endpoint not reported